Berenice Curro’s Post

Did you know that it takes on average 5.6 years to be diagnosed with the right genetic condition? But change is already happening thanks to UK scientists! 🌟 After a Cambridge and NIHR BioResource-supported study in 2019, now all seriously ill children in England with an unexplained disorder are eligible for genome analysis for faster diagnosis. This was thanks to amazing hero participants supporting research. All children between the ages of 0-15 can join D-CYPHR online to help with health research. All it takes is a questionnaire and a spit sample. Maybe your family could be part of the next big discovery? Support families with genetic conditions and share your support for children’s health research! Join us now. Visit: https://lnkd.in/ezkJB6JY NIHR BioResource Centre Newcastle Anna Freud Birmingham Women's and Children's NHS Foundation Trust Cambridge University Hospitals NHS Foundation Trust #dcyphr #healthresearch #nhs #researchstudy #helpingothers #BioResource #NIHR #thepowerofspit #geneticcondition #healthissues

Meet Samyam, a doctor from Nepal who has taken 43 courses on FutureLearn, mostly in healthcare. He credits FutureLearn with helping him improve his skills in genetic counseling, patient management, and psychological first aid. 🙌 Learn more about how FutureLearn can help you advance your career in healthcare at https://bit.ly/3rY5D8V 🔗 #FutureLearn #Learnwithus

As we near the end of Antiphospholipid Awareness Month, take a moment to delve into the world of thrombosis and Antiphospholipid Syndrome awareness. 🔗 https://lnkd.in/eAjdh2Hh Watch now and gain insights from @Dr. Stephan Moll, a renowned hematologist and thrombosis specialist as he provides a comprehensive overview of Antiphospholipid Syndrome (aPS), addressing topics such as testing for antiphospholipid antibodies (APLA), valuable references for clinicians, and essential patient advocacy groups. For a deeper understanding of laboratory testing for aPS and patient experiences, don't miss the enlightening discussion available on YouTube. #APS #APSawareness #Lupus #Awareness #Stago #supportgroups #miscarriages #Thrombosis #antiphospholipidsyndromeawareness #education #awareness #pregnancyloss #anticoagulants #advocacy #awarenessmonth #Stroke #antiphospholipidsyndrome #NationalBloodClot #ApsFoundationofAmerica

NCERT Class 12 Biology MCQ : Human Reproduction Embark on a journey through the intricacies of "Human Reproduction" with our dedicated MCQs page, meticulously crafted to prepare you for success in various sector exams, including the prestigious UPSC IAS. Dive into the realm of reproductive biology, exploring questions sourced from Previous Year Papers that challenge and reinforce your knowledge. #CompetitiveExams #ContraceptionMethods #FertilityTreatments #HumanReproduction #MCQs #ReproductiveAnatomy #ReproductiveBiology #UPSCIAS https://lnkd.in/dRzvJdux

𝐌𝐄𝐑𝐋𝐍 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐬 𝐭𝐡𝐞 𝐅𝐢𝐫𝐬𝐭 𝐌𝐨𝐝𝐞𝐥 𝐟𝐨𝐫 𝐌𝐨𝐧𝐨𝐳𝐲𝐠𝐨𝐭𝐢𝐜 𝐓𝐰𝐢𝐧𝐧𝐢𝐧𝐠 In collaboration with Maastricht UMC+ and the University of Exeter, a team of researchers from the MERLN institute, under supervision of Erik Vrij, has developed the first-ever model for monozygotic (identical) twin development! In the video below the scientists explain their research and the implications it can for understanding of twin development, and reproductive health. Read the full scientific article here: https://lnkd.in/eZvTs3F5

I'm involved in this project and learning about cell biology and more. It's fascinating. I will serve as a panelist to share my experience of discrimination while engaged with healthcare systems. https://lnkd.in/e3-N9T4F #healthequity #minoritystresstheory

Happy 2024, everyone! As we enter the new year, we wanted to point out a few important upcoming deadlines: 1. Late-breaking abstracts are due January 12. The purpose of the late breaking submission of abstracts is to give researchers the opportunity to report recently generated research on important basic, translational or clinical discoveries in reproductive health. The deadline will NOT be extended, so make sure you give yourself enough time to gather all of your materials! https://lnkd.in/g4krtVFt 2. The Annual Meeting URM registration discount application is also due next Friday, January 12. With this, 25 individuals who are underrepresented in their country or originate from a low-income, lower-middle-income, or upper-middle-income country (as defined by the World Bank) will receive a significant registration discount, with a flat rate of $100 for their Annual Meeting registration. You can submit your application and learn more here: https://lnkd.in/gKmykTWh 3. Lastly, advanced registration will be closing on January 22nd- after this date, registration prices will increase, so hurry and register today to receive the best rates! https://lnkd.in/gKmykTWh

At the Dysmenorrhea Project, we take personal and academic development outside of the research itself very seriously. That is why our team members are urged to look and read outside the scope of the project and write Letters to the Editor regarding topics they are passionate about. We are excited to announce that Poppy Sullivan and Sabthagi Sivathasan's recent Letter to the Editor regarding 'Quality testing of mifepristone and misoprostol in 11 countries' has been published in BJOG! In this letter, they discuss the article that conducted the systematic review on this subject and tackle the ethical implications of these drugs that are so widely used but so little is known about them. To read the full article, please find it here: https://lnkd.in/e8FW6Yu6

From the beginning of my graduate training at Vanderbilt University studying human genetics, I was struck by the very real possibility that within my lifetime we would start to see cures developed for rare, #geneticdiseases. My dissertation focused on the implementation of #precisionmedicine--what it takes scientifically, technically, and most importantly: the ethical, legal, and social issues (#ELSI) to ensure patient values and preferences are at the heart of #medicalinnovation. And I've spent my post-training career considering these important questions from nearly every angle of the healthcare ecosystem.   So, it should come as no surprise to hear that I've been following the #sicklecelldisease treatment approvals with great interest. If you're not familiar with #SCD, I recommend heading over to the Sick Cells website and getting educated. It's a devastating disease.    But what my time in each of my roles has taught me, is that ensuring equitable access to this and other curative diseases will be complicated, involve many stakeholders, and probably be fraught with failures along the way. I am looking forward to conversations in 2024 around this topic. I have lots of ideas and even more questions--like how do we pay for these treatments? How can we accurately and completely measure the value of a cure? How do we make sure that *every* patient voice is heard for their values and preferences? What are the ethical challenges we still have yet to properly address so that we don't amplify existing health disparities?   So if you're also thinking hard questions about all of the potential cures coming in the next decade, let's chat in the new year! I look forward to spirited debate with open minds, sharing evidence, and ensuring patients don't get left behind. #healthequity #healthdisparities #heor #bioethics #patientvoice #valuebasedcare

Thoughtful commentary today in #IJE by Professor Neil Davies (UCL Division of Psychiatry), Liam Wright & David Bann (UCL Institute of Epidemiology and Health Care) and Emilie Courtin (The London School of Economics and Political Science (LSE)) on the problematic pressure to draw policy conclusions based on single studies. "Researchers are increasingly expected to draw policy implications from their research, yet this can be distracting or misleading when describing single studies. Rather than helping ensure that research benefits society, it may distort research and evidence-based policy... "when articles make unfounded policy conclusions based on single studies, they risk undermining trust in the discipline and science as a whole." https://lnkd.in/dyD-bQgC.